Park I

References (3)

Title : Low-Dose Neostigmine at 0.7 Train-of-Four Ratio Safely Accelerates Neuromuscular Recovery: A Prospective Observational Study - Koo_2026_Drug.Des.Devel.Ther_20_587354
Author(s) : Koo CH , Choi CI , Park I , Lee S , Oh AY
Ref : Drug Des Devel Ther , 20 :587354 , 2026
Abstract :
PubMedSearch : Koo_2026_Drug.Des.Devel.Ther_20_587354
PubMedID: 41913738

Title : Standardized Hydroxytyrosol-Enriched Olive Pomace Juice Modulates Metabolic and Neurotrophic Signaling Pathways to Attenuate Neuroinflammation and Protect Neuronal Cells - You_2026_Molecules_31_
Author(s) : You YL , Byun HJ , Kang N , Lee MS , Lee JI , Park I , Choi HS
Ref : Molecules , 31 : , 2026
Abstract :
PubMedSearch : You_2026_Molecules_31_
PubMedID: 41599384

Title : Configurational Assignment of a Flexible Benzo[g]isochromene Stereodiad from Rubia philippinensis and Inhibition of Soluble Epoxide Hydrolase Activity - Quan_2021_J.Nat.Prod__
Author(s) : Quan KT , Park I , Kim CS , Yoshida W , Ferreira D , Thuong PT , Kim YH , Na M , Oh J
Ref : Journal of Natural Products , : , 2021
Abstract :
PubMedSearch : Quan_2021_J.Nat.Prod__
PubMedID: 34427436